Results 191 to 200 of about 117,810 (327)

Safety and efficacy of the therapy with CD4 + CD25highCD127‐T regulatory cells: When paediatric patient becomes adult

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1392-1402, February 2026.
Abstract Aim CD4 + CD25highCD127‐T regulatory cells (Tregs) remain a drug candidate for immunotherapy of type 1 diabetes. We completed three trials testing Tregs in recently diagnosed type 1 diabetes children. Here, we looked for long‐term safety and efficacy aspects important in the authorisation of this therapy.
Marta Bandura, Magdalena Piotrowska‐Mieczkowska, Matylda Hennig, Mateusz Gliwiński, Anna Wołoszyn‐Durkiewicz, Julia Schoenhoff, Milena Dybowska, Anna Alska, Piotr Gutknecht, Bartosz Trzeciak, Katarzyna Stefańska, Paulina Glasner, Marcin Hellmann, Jacek Burzyński, Arkadiusz Michalak, Janusz Siebert, Dorota Iwaszkiewicz‐Grześ, Małgorzata Myśliwiec, Piotr Trzonkowski   +18 more
wiley   +1 more source

Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management

Journal of Internal Medicine, Volume 299, Issue 2, Page 196-215, February 2026.
Abstract Cryoglobulinemia (CG) is defined by the presence of serum immunoglobulins that precipitate below 37°C and redissolve upon rewarming. It is classified into three types based on immunoglobulin composition. Type I, a rare form, involves monoclonal IgM or IgG and is linked to lymphoproliferative disorders.
Anna Linda Zignego, Laura Gragnani, Marcella Visentini, Riccardo Bomben, Luca Arcaini, Clodoveo Ferri, Valter Gattei, Cesare Mazzaro   +7 more
wiley   +1 more source

Graves’ hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA

, 2003
Jeffrey C. Flynn, Prakash Rao, Monika Góra, Ghazwan Alsharabi, Wenjing Wei, Alvaro A. Giraldo, Chella S. David, J. Paul Banga, Yi‐chi M. Kong   +8 more
openalex   +1 more source

Positive Anti-GABAB Receptor Antibodies in a Patient with Hashimoto’s Thyroiditis and Bipolar Affective Disorder [PDF]

, 2021
Полина Анатольевна Соболевская, Andreev Bv, Leonid P. Churilov, Tamara V. Fedotkina, Boris Gilburd, Aliya K. Stanova, Vladimir J. Utekhin, Yehuda Shoenfeld   +7 more
openalex   +1 more source

Manifestations of thyroid disease post COVID-19 illness: Report of Hashimoto thyroiditis, Graves’ disease, and subacute thyroiditis

Journal of Clinical and Translational Endocrinology: Case Reports, 2021
K. Feghali, Jacqueline Atallah, Catalina Norman   +2 more
semanticscholar   +1 more source

New‐onset autoimmune disease following SARS‐CoV‐2 infection and mRNA vaccination in Norway: A retrospective cohort study

Journal of Internal Medicine, Volume 299, Issue 2, Page 271-282, February 2026.
Abstract Background Studies suggest an increase in autoimmune diseases following SARS‐CoV‐2 infection and/or COVID‐19‐vaccination. We aimed to describe possible associations in Norway. Methods We used information from the emergency preparedness register for COVID‐19, BeredtC19, for all residents aged 18–64 (N = 3,450,080).
Håkon Bøås, Paz Lopez‐Doriga Ruiz, Jesper Dahl, Hanne L. Gulseth, German Tapia   +4 more
wiley   +1 more source

Popular co-occurrence of thyroid autoimmune disorders and specific gastrointestinal tract diseases

Journal of Education, Health and Sport, 2019
Introduction: Thyroid gland, despite of its small average size, is a crucial organ of human body. Hormones produced by the thyroid i.e. thyroxine (T4) and triiodothyronine (T3) are necessary for proper functioning the whole organism.
Ewa Tywanek, Magdalena Woźniak, Agnieszka Zwolak, Robert Jan Łuczyk   +3 more
doaj  

Recurrent Painful Hashimoto Thyroiditis Successfully Treated by Thyroidectomy [PDF]

, 2019
Carol Chiung‐Hui Peng, Kashif M. Munir, Linda Song, John C. Papadimitriou, M Pennant   +4 more
openalex   +1 more source

Effect study's the role of serum vitamin D3 level in Hashimoto's thyroiditis disease

, 2022
Lara Balasim Al-Dahy, Maha Raad Hashim Al-Sammarraie, Ammar Jawad Al Chaabawi   +2 more
openalex   +2 more sources

Submaximal 2‐day cardiopulmonary exercise testing to assess exercise capacity and post‐exertional symptom exacerbation in people with long COVID

Experimental Physiology, Volume 111, Issue 2, Page 435-448, 1 February 2026.
Abstract Long COVID has a complex pathology and a heterogeneous symptom profile that impacts quality of life and functional status. Post‐exertional symptom exacerbation (PESE) affects one‐third of people living with long COVID, but the physiological basis of impaired physical function remains poorly understood. Sixty‐eight people (age (mean ± SD): 50 ± 
Callum Thomas, Nik Kudiersky, Paul Ansdell, Ruth E Ashton, Calum Brown, Thomas Bewick, Jack Carr, Emily Hume, Padraig Spillane, Elisa Pastorio, Rebecca Owen, Tom Maden‐Wilkinson, Ethan McNeil‐Angopa, Tom Parkington, Ross Arena, Cemal Ozemek, Federico Formenti, Sundar Kumar Veluswamy, Rachita Gururaj, Mark A. Faghy   +19 more
wiley   +1 more source